Literature DB >> 30703431

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Craig T January, L Samuel Wann, Hugh Calkins, Lin Y Chen, Joaquin E Cigarroa, Joseph C Cleveland, Patrick T Ellinor, Michael D Ezekowitz, Michael E Field, Karen L Furie, Paul A Heidenreich, Katherine T Murray, Julie B Shea, Cynthia M Tracy, Clyde W Yancy.   

Abstract

Entities:  

Keywords:  ACC/AHA Clinical Practice Guidelines; acute coronary syndrome; anticoagulants; anticoagulation agents; antiplatelet agents; apixaban; atrial fibrillation; atrial flutter; cardioversion; coronary artery disease; coronary heart disease; dabigatran; edoxaban; focused update; hypertension; idarucizumab; myocardial infarction; obesity; percutaneous coronary intervention; risk factors; rivaroxaban; sleep apnea; stents; stroke; thromboembolism; warfarin

Mesh：

Year:  2019        PMID： 30703431     DOI： 10.1016/j.jacc.2019.01.011

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  349 in total

1.  Detection of atrial fibrillation using an implantable loop recorder following cryptogenic stroke: implications for post-stroke electrocardiographic monitoring.

Authors:  Nicolle S Milstein; Dan L Musat; James Allred; Amber Seiler; Jacqueline Pimienta; Susan Oliveros; Advay G Bhatt; Mark Preminger; Tina Sichrovsky; Richard E Shaw; Suneet Mittal
Journal:  J Interv Card Electrophysiol       Date:  2019-10-14       Impact factor: 1.900

Review 2.  Electrophysiologic Complications in Cancer Patients.

Authors:  Dae Hyun Lee; Sanjay Chandrashekhar; Michael G Fradley
Journal:  Methodist Debakey Cardiovasc J       Date:  2019 Oct-Dec

3.  Improving Anticoagulant Treatment Strategies of Atrial Fibrillation Using Reinforcement Learning.

Authors:  Lei Zuo; Xin Du; Wei Zhao; Chao Jiang; Shijun Xia; Liu He; Rong Liu; Ribo Tang; Rong Bai; Jianzeng Dong; Xingzhi Sun; Gang Hu; Guotong Xie; Changsheng Ma
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

4.  The fading role of triple therapy in patients with atrial fibrillation and acute coronary syndrome: a Bayesian network meta-analysis.

Authors:  Mohammed Osman; Babikir Kheiri; Muhammad Bilal Munir; Jason A Moreland; Sudarshan Balla; Samir Kapadia
Journal:  J Thromb Thrombolysis       Date:  2019-10       Impact factor: 2.300

5.  Dual versus triple therapy for patients with atrial fibrillation and acute coronary syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials.

Authors:  Babikir Kheiri; Mohammed Osman; Ahmed Bakhit; Qais Radaideh; Ahmed Abdalla; Mahmoud Barbarawi; Yazan Zayed; Sahar Ahmed; Ghassan Bachuwa; Mustafa Hassan
Journal:  J Thromb Thrombolysis       Date:  2019-10       Impact factor: 2.300

6.  Stroke prevention in atrial fibrillation: the Singapore story.

Authors:  Pow-Li Chia
Journal:  Singapore Med J       Date:  2020-12       Impact factor: 1.858

7.  Combination of Oral Anticoagulants and Single Antiplatelets versus Triple Therapy in Nonvalvular Atrial Fibrillation and Acute Coronary Syndrome: Stroke Prevention among Asians.

Authors:  Anwar Santoso; Sunu B Raharjo
Journal:  Int J Angiol       Date:  2020-05-06

8.  The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding.

Authors:  Sarah Hanigan; Jessica Das; Kristen Pogue; Geoffrey D Barnes; Michael P Dorsch
Journal:  J Thromb Thrombolysis       Date:  2020-05       Impact factor: 2.300

9.  Comparative Safety and Effectiveness of Direct-Acting Oral Anticoagulants Versus Warfarin: a National Cohort Study of Nursing Home Residents.

Authors:  Matthew Alcusky; Jennifer Tjia; David D McManus; Anne L Hume; Marc Fisher; Kate L Lapane
Journal:  J Gen Intern Med       Date:  2020-04-06       Impact factor: 5.128

10.  Left atrial appendage occlusion with the Amplatzer™ Amulet™ device: full results of the prospective global observational study.

Authors:  David Hildick-Smith; Ulf Landmesser; A John Camm; Hans-Christoph Diener; Vince Paul; Boris Schmidt; Magnus Settergren; Emmanuel Teiger; Jens Erik Nielsen-Kudsk; Claudio Tondo
Journal:  Eur Heart J       Date:  2020-08-07       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.